MEP10209A - Stable emulsion composition - Google Patents
Stable emulsion compositionInfo
- Publication number
- MEP10209A MEP10209A MEP-102/09A MEP10209A MEP10209A ME P10209 A MEP10209 A ME P10209A ME P10209 A MEP10209 A ME P10209A ME P10209 A MEP10209 A ME P10209A
- Authority
- ME
- Montenegro
- Prior art keywords
- emulsion composition
- stable emulsion
- stable
- compaction
- emulsion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
Abstract
Ovaj pronalayak obezbjeđuje emulzionu kompeyaciju koja uključuje (A) jedinjenje stabilno u kisjelom opsegu, i (B) pufer, pri čemu je pH vrijednost podešena od približno 3.7 do približno 5.5.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005131807 | 2005-04-28 | ||
PCT/JP2006/309213 WO2006118329A1 (ja) | 2005-04-28 | 2006-04-27 | 安定な乳化組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP10209A true MEP10209A (en) | 2011-12-20 |
Family
ID=37308111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-102/09A MEP10209A (en) | 2005-04-28 | 2006-04-27 | Stable emulsion composition |
Country Status (24)
Country | Link |
---|---|
US (1) | US20100016381A1 (bs) |
EP (2) | EP1875926A4 (bs) |
JP (2) | JP5236287B2 (bs) |
KR (1) | KR101321633B1 (bs) |
CN (2) | CN102670503A (bs) |
AR (1) | AR054264A1 (bs) |
AU (1) | AU2006241671B2 (bs) |
BR (1) | BRPI0610029A2 (bs) |
CA (1) | CA2605773C (bs) |
CR (2) | CR9495A (bs) |
GE (1) | GEP20105031B (bs) |
IL (1) | IL186673A (bs) |
MA (1) | MA29487B1 (bs) |
ME (1) | MEP10209A (bs) |
MX (1) | MX2007013407A (bs) |
MY (1) | MY147790A (bs) |
NO (1) | NO20075985L (bs) |
NZ (1) | NZ563225A (bs) |
PE (1) | PE20061437A1 (bs) |
RU (1) | RU2428204C2 (bs) |
TW (1) | TWI462745B (bs) |
UA (1) | UA97346C2 (bs) |
WO (1) | WO2006118329A1 (bs) |
ZA (1) | ZA200710193B (bs) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090105314A1 (en) * | 2006-05-15 | 2009-04-23 | Takeda Pharmaceutical Company Limited | Pharmaceutical Agent |
WO2008060934A2 (en) * | 2006-11-14 | 2008-05-22 | Acusphere, Inc. | Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
US20080234376A1 (en) * | 2007-03-21 | 2008-09-25 | Taiwan Liposome Company (A Taiwan Corporation) | Emulsion composition comprising prostaglandin e1 |
CN101229174B (zh) * | 2008-01-25 | 2010-12-15 | 广东一品红药业有限公司 | 一种含有盐酸依匹斯汀的抗过敏组合物 |
US7829513B2 (en) * | 2009-03-12 | 2010-11-09 | Greenology Products, Inc. | Organic cleaning composition |
SG10201503402XA (en) | 2010-01-27 | 2015-06-29 | Takeda Pharmaceutical | Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent |
CN107049941A (zh) * | 2011-03-31 | 2017-08-18 | 富士胶片株式会社 | 含有前列腺素的脂肪乳剂 |
JP2012214430A (ja) * | 2011-03-31 | 2012-11-08 | Fujifilm Corp | プロスタグランジン含有脂肪乳剤 |
JP5894752B2 (ja) * | 2011-03-31 | 2016-03-30 | 富士フイルム株式会社 | プロスタグランジン含有脂肪乳剤 |
KR102200176B1 (ko) | 2012-05-08 | 2021-01-11 | 에어로믹스, 인코포레이티드 | 신규 방법 |
EP3065729A4 (en) | 2013-11-06 | 2017-05-31 | Aeromics, Inc. | Novel formulations |
US20170246136A1 (en) * | 2014-09-24 | 2017-08-31 | OliVentures, Inc. | Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases |
WO2017196979A1 (en) * | 2016-05-10 | 2017-11-16 | The Regents Of The University Of Michigan | Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration |
WO2021252449A1 (en) * | 2020-06-08 | 2021-12-16 | Harm Reduction Therapeutics, Inc. | Sterilized formulations |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128339A (en) * | 1990-11-01 | 1992-07-07 | Sterling Winthrop Inc. | Proteolytic enzyme inhibition method |
US5236917A (en) * | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
US5380737A (en) * | 1989-05-04 | 1995-01-10 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
US5306818A (en) * | 1990-11-01 | 1994-04-26 | Sterling Winthrop Inc. | Tetrahydro 2-saccharinylmerthyl aryl carboxylates |
US5512589A (en) * | 1990-11-01 | 1996-04-30 | Sterling Winthrop Inc. | 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
US5250696A (en) * | 1990-11-01 | 1993-10-05 | Sterling Winthrop Inc. | 2-saccharinylmethyl aryl carboxylate |
JP2836599B2 (ja) | 1996-08-09 | 1998-12-14 | 日本電気株式会社 | 通信制御装置 |
AU747521B2 (en) * | 1998-03-09 | 2002-05-16 | Takeda Pharmaceutical Company Limited | Cycloalkene derivatives, process for producing the same, and use |
CH693846A5 (de) | 1998-03-11 | 2004-03-15 | Mitsubishi Electric Corp | Gronlingelektrode zur Oberflachenbehandlung durch Funkenerosion. |
DE60045033D1 (de) * | 1999-08-06 | 2010-11-11 | Takeda Pharmaceutical | Substituierte aromatische ringverbindungen, verfahren zu ihrer herstellung und ihre anwendung |
US6532316B1 (en) * | 1999-11-10 | 2003-03-11 | Avanex Corporation | Bi-directional polarization-independent optical isolator |
KR100784752B1 (ko) * | 2000-02-04 | 2007-12-13 | 다케다 야쿠힌 고교 가부시키가이샤 | 안정한 에멀젼 조성물 |
JP4863553B2 (ja) * | 2000-02-04 | 2012-01-25 | 武田薬品工業株式会社 | 安定な乳化組成物 |
JP2003033195A (ja) * | 2001-07-24 | 2003-02-04 | Kyowa Hakko Kogyo Co Ltd | テトラヒドロクルクミン類の製造方法 |
WO2003013513A1 (en) * | 2001-08-03 | 2003-02-20 | Takeda Chemical Industries, Ltd. | Stable emulsion composition |
US20030220284A1 (en) * | 2002-02-22 | 2003-11-27 | Patricia Yotnda | Delivery of adenoviral DNA in a liposomal formulation for treatment of disease |
EP1576953A4 (en) * | 2002-12-06 | 2008-08-06 | Otsuka Pharma Co Ltd | FATTY EMULSIONS CONTAINING PROPOFOL |
NZ546231A (en) * | 2003-10-03 | 2009-09-25 | Ono Pharmaceutical Co | Drug containing (2R)-2-propyloctanoic acid as the active ingredient |
EP2260869A3 (en) * | 2006-04-20 | 2011-03-23 | Takeda Pharmaceutical Company Limited | Pharmaceutical product |
-
2006
- 2006-04-26 MY MYPI20061928A patent/MY147790A/en unknown
- 2006-04-26 TW TW095114843A patent/TWI462745B/zh not_active IP Right Cessation
- 2006-04-27 EP EP06746045A patent/EP1875926A4/en not_active Withdrawn
- 2006-04-27 GE GEAP200610396A patent/GEP20105031B/en unknown
- 2006-04-27 US US11/919,373 patent/US20100016381A1/en not_active Abandoned
- 2006-04-27 BR BRPI0610029-5A patent/BRPI0610029A2/pt not_active IP Right Cessation
- 2006-04-27 CA CA2605773A patent/CA2605773C/en not_active Expired - Fee Related
- 2006-04-27 ZA ZA200710193A patent/ZA200710193B/xx unknown
- 2006-04-27 AU AU2006241671A patent/AU2006241671B2/en not_active Ceased
- 2006-04-27 EP EP10172992A patent/EP2255785A3/en not_active Withdrawn
- 2006-04-27 CN CN2012101563870A patent/CN102670503A/zh active Pending
- 2006-04-27 MX MX2007013407A patent/MX2007013407A/es active IP Right Grant
- 2006-04-27 PE PE2006000447A patent/PE20061437A1/es not_active Application Discontinuation
- 2006-04-27 WO PCT/JP2006/309213 patent/WO2006118329A1/ja active Application Filing
- 2006-04-27 UA UAA200713277A patent/UA97346C2/ru unknown
- 2006-04-27 RU RU2007144071/04A patent/RU2428204C2/ru not_active IP Right Cessation
- 2006-04-27 NZ NZ563225A patent/NZ563225A/en not_active IP Right Cessation
- 2006-04-27 KR KR1020077027773A patent/KR101321633B1/ko not_active IP Right Cessation
- 2006-04-27 AR AR20060101689A patent/AR054264A1/es unknown
- 2006-04-27 CN CN200680023521.2A patent/CN101212986B/zh not_active Expired - Fee Related
- 2006-04-27 JP JP2007514873A patent/JP5236287B2/ja not_active Expired - Fee Related
- 2006-04-27 ME MEP-102/09A patent/MEP10209A/xx unknown
-
2007
- 2007-10-15 IL IL186673A patent/IL186673A/en not_active IP Right Cessation
- 2007-11-02 CR CR9495A patent/CR9495A/es unknown
- 2007-11-21 NO NO20075985A patent/NO20075985L/no not_active Application Discontinuation
- 2007-11-26 MA MA30421A patent/MA29487B1/fr unknown
-
2012
- 2012-11-27 JP JP2012259121A patent/JP2013040215A/ja active Pending
-
2013
- 2013-12-17 CR CR20130666A patent/CR20130666A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP10209A (en) | Stable emulsion composition | |
AR110313A2 (es) | Derivados de tiazol-2-il-pirrolidina | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
CR8824A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
DK1791571T3 (da) | Radiofluorinerede peptider | |
DE602006010979D1 (de) | Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen | |
RS54217B1 (en) | SOME TRIAZOLOPIRAZINS, THEIR COMPOSITIONS AND THE METHODS OF USING THEM | |
CY1113199T1 (el) | Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης | |
DE602006018856D1 (de) | Neue nutrazeutika-zusammensetzungen | |
MX2009006594A (es) | Formulaciones de ph regulado y estables que contienen polipeptidos. | |
BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
BRPI0813341A2 (pt) | " uso de compostos, composições curáveis, e, uso de composições curáveis ". | |
CY1112950T1 (el) | Νηματωδοκτονες συνθεσεις | |
RS50629B (sr) | Amidni prolek gemcitabina, kompozicije i njihova primena | |
ATE459620T1 (de) | Benzimidazolthiophenverbindungen als plk- modulatoren | |
DE602004018512D1 (de) | Stifte zusammensetzungen | |
MY145644A (en) | 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists | |
EA200601596A1 (ru) | Улучшенный состав 6-меркаптопурина | |
ATE452646T1 (de) | Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat | |
MX341064B (es) | Variantes de la familia il-1. | |
BR0300119B1 (pt) | composiÇço aquosa. | |
ATE461189T1 (de) | Neue 6-pyridylphenanthridine | |
EA200800820A1 (ru) | Композиция с замедленным высвобождением и ее применение |